Tezspire, Injektionslösung in einer Fertigspritze

7680684540011 CH-68454 Injektionslösung

Associated product:

TEZSPIRE sol inj 210 mg/1.91ml ser pré 1.91 ml
Tezspire, Injektionslösung in einer Fertigspritze
Tezspire, Injektionslösung in einer Fertigspritze
Tezspire, Injektionslösung in einer Fertigspritze
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
30/10/2023
Patient information leaflet
Français
30/10/2023
Patient information leaflet
Italien
30/10/2023
Summary of Product Characteristics
Allemand
30/10/2023
Summary of Product Characteristics
Français
30/10/2023
Summary of Product Characteristics
Italien
30/10/2023

Detailed composition

Substance Quantity Type Category
(N/A)
210.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1143.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2023

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
68454
Drug name
Tezspire, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
R03DX11
Authorization status
Z
Dispensing category
B
First authorization
13/06/2022
Authorization expiration date
12/06/2027
IT Number
03.04.5.
Domain
Human medicine
Field of application
Zusatztherapie bei schwerem Asthma

Package details

Description (FR)
TEZSPIRE sol inj 210 mg/1.91ml ser pré 1.91 ml
Description (DE)
TEZSPIRE Inj Lös 210 mg/1.91ml Fertspr 1.91 ml
Market launch
13/06/2022
Narcotic (BTM)
No